CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

yahoo_finance
Original article

Wall Street Analysts Believe Nurix Therapeutics (NRIX) Could Rally 29.23%: Here's is How to Trade

Positive
AI Analysis

Summary

Wall Street analysts have assigned a price target for Nurix Therapeutics (NRIX) suggesting potential upside of 29.23%. The article provides analyst perspective on the company's valuation.

Importance:2/10
Sentiment:
0.50
analyst_ratingstock_price_target
Related Companies

Read the original article

Published by yahoo_finance on July 1, 2026 1:55 PM

Read Original